Antiangiogenic and anticancer activity of saponins of Momordica cymbalaria


  • Raju Koneri Department of Pharmacology, Karnataka College of pharmacy, Bangalore-560001, Karnataka, India
  • Nagarathna P. K. M. Department of Pharmacology, Karnataka College of pharmacy, Bangalore-560001, Karnataka, India
  • Mubasheera M. G. Department of Pharmacology, Karnataka College of pharmacy, Bangalore-560001, Karnataka, India
  • M. Madhu Mohan Department of Pharmacology, Karnataka College of pharmacy, Bangalore-560001, Karnataka, India


Ehrlich ascetic cells, Antiangiogenesis, Momordica cymbalaria, CAM, Air sac model, Erythropoietin, Carrageenin, MTT


Background: The aim of the current study was to evaluate invitro anticancer activity of saponins of MC on EAC cells by using cytotoxicity (MTT) assay. To evaluate in vivo antiangiogenic potential of saponins of MC on rat air sac angiogenesis, EAC induced peritoneal angiogenesis, CAM angiogenesis.

Methods: MTT assay was carried out at different concentrations of saponins of MC in 12 microliter plates containing media with EAC cells. In rat air sac angiogenesis, carrageenin was injected (s.c.) into the air sac. Dexamethasone, indomethacin, saponins of MC was administered to identify the angiogenic activity. In EAC induced angiogenesis in peritoneum, EAC cells were administered through i.p in mice peritoneum. 5-fluoro uracil, (i.p) and saponins of MC (orally) was given to identify angiogenic activity. In CAM angiogenesis, erythropoietin was given to eggs on 8th day of incubation. saponins were given on the 12th day for two days to observe the antiangiogenic activity.

Results: The observed cytotoxic effects of saponins of MC on EAC cells find statistically significant. There is significant reduction in vascular branching in rat air sac model; EAC induced peritoneal angiogenesis, CAM model by the saponins of MC.

Conclusions: Due to lack of certain records, it is envisaged that the change of medicine both discontinuation as well as addition was done because of blood glucose control, cost factor [in case of pioglitazone] as well as patient’s compliance.


Shoeb M. Anticancer agents from medicinal plants. Bangladesh J Phamacol. 2006;1:35-41.

Michael R, Boyd, Kenneth D, Paull. Some Practical Considerations and Applications of the National Cancer Institute In vitro Anticancer Drug Discovery Screen Drug development research.1995;34:91-109.

Sheela M. Lingaraju, Keshavaiah K, Salimath BP. Inhibition of in vivo angiogenesis by Anacardiumoccidentale L. involves repression of the cytokine VEGF gene expression. Drug Discov Ther 2008;2(4):234-44.

Folkman J. Tumor angiogenesis. Therapeutic implications. N Engl J Med. 1971;285:1182-6.

Tortora G, Melisi D, Ciardiello F. Angiogenesis: A target foe cancer therapy. Curr Pharma Design. 2004;10:11-26.

Aisha A, M. Abu-Salah K, Ismail Z, Abdul Majid A. Screening for Antiangiogenesis Activity in Natural Products: A Review. Webmed Central Pharmacology. 2010;1(12):WMC001315.

Cardenas C, Quesada AR, Medina MA. Evaluation of the angiogenic effect of aloe-emodin. Cell Mol Life Sci. 2006;63:3083-9.

Koneri R, Saraswati CD, Balaraman R, Ajeesha EA. Antiimplantation activity of the ethanolic root extract of Momordica cymbalaria Fenzl in rats. Indian J Pharmacol. 2007;9:90-6.

Swamy VBM, Jayaveera KN. Antimicrobial properties of Momordica cymbalaria hook. F.Pharmacologyonline. 2007;3:505-10.

Koneri R, Balaraman R, Hariprasad, Vinoth Kumar M, Ali A. Cardioprotective effect of Momordica Cymbalaria fenzl in rats with Isoproterenol-induced myocardial injury. Journal of Clinical and Diagnostic Research. 2008;2:699-705.

Dhasan PB, Jegadeesan M, Kavimani S. Antiulcer activity of aqueous extract of fruits of Momordica cymbalaria hook f. in wistar rats. Phcog Res. 2010Jan;2(1):58-61.

Kumar P, DevalRao G, Lakshmayya, Ramachandra SS. Antioxidant and hepatoprotective activity of tubers of Momordica tuberose Cogn. Against CCl4 induced liver injury in rats. Indian J Exp Biol. 2008Jul;46:510-13.

Kameswara Rao B, Kesavulu MM, Giri R, AppaRao CH. Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. Fruit powder in alloxan-diabetic rats. Journal of Ethnopharmacology. 1999;67:103-9.

KameswaraRao B, Kesavulu MM, AppaRao CH. Antihyperglycemic activity of Momordica cymbalaria in alloxan diabetic rats. Journal of Ethnopharmacology. 2001;78:67-71.

Rajasekhar MD, Kameswara Rao B, Kumar KV, RameshBabu K,Sameena SF, Sampath Kumar MT et al. Isolation and characterization of a novel antihyperglycemic protein from the fruits of Momordica cymbalaria. Journal of Ethnopharmacology. 2010;128:58-62.

Vijayabaskaran M, Yuvaraj KR, Saravanakumar M, Abhenaya K. Evaluation of invitro cytotoxic activity of ethanolic extract of Symplocos racemosa Roxb. International Journal of Pharmaceutical and Clinical Research. 2010;2(1):28-30.

Marcsek Z, Kocsis Z, Jakab M, Szende, Tompa A. The Efficacy of Tamoxifen in Estrogen Receptor–Positive Breast Cancer Cells Is Enhanced by a Medical Nutriment. Cancer Biother Radiopharm. 2004;19(6):746-53.




How to Cite

Koneri, R., M., N. P. K., G., M. M., & Mohan, M. M. (2017). Antiangiogenic and anticancer activity of saponins of Momordica cymbalaria. International Journal of Basic & Clinical Pharmacology, 3(1), 70–78. Retrieved from



Original Research Articles